The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells

Published:2017-09-27 Issue:58 Volume:8 Page:98348-98359
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Yu Tianfu¹,Wang Yingyi¹,Hu Qi¹,Wu WeiNing¹,Wu Youzhi²,Wei Wenjin³,Han Dongfeng⁴,You Yongping¹,Lin Ning⁵,Liu Ning¹

Affiliation:

1. Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

2. Department of Neurosurgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

3. Department of Neurosurgery, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou, Jiangxi Province, China

4. Department of Neurosurgery, Xuzhou Central Hospital, Xuzhou, China

5. Department of Neurosurgery, The First People's Hospital Chuzhou, Chuzhou, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bisphenol S (BPS) induces glioblastoma progression via regulation of EZH2-mediated PI3K/AKT/mTOR pathway in U87-MG cells;Toxicology;2024-09

2. EZH2 Inhibition to Counteract Oral Cancer Progression through Wnt/β-Catenin Pathway Modulation;Pharmaceuticals;2024-08-22

3. Combined inhibition of EZH2 and CDK4/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma;npj Precision Oncology;2024-07-25

4. The Role of Mesenchymal Reprogramming in Malignant Clonal Evolution and Intra-Tumoral Heterogeneity in Glioblastoma;Cells;2024-05-30

5. Uracil‐ and Pyridine‐Containing HDAC Inhibitors Displayed Cytotoxicity in Colorectal and Glioblastoma Cancer Stem Cells;ChemMedChem;2024-04-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3